Last reviewed · How we verify
Calcipotriol aerosol spray
At a glance
| Generic name | Calcipotriol aerosol spray |
|---|---|
| Sponsor | LEO Pharma |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) (PHASE2)
- Efficacy and Tolerability of Enstilar® in Daily Practice
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcipotriol aerosol spray CI brief — competitive landscape report
- Calcipotriol aerosol spray updates RSS · CI watch RSS
- LEO Pharma portfolio CI